Latest Insights - page 87 | BiopharmaTrend

[Interview] How COVID-19 Catalyzed AI-assisted Open Science Drug Discovery

Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of our time. One notable effort is the COVID Moonshot project, …

Continue ›››

The Increasing Potential of Virtual Reality in Drug Design

Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological opportunity, which increasingly grabs attention among scientists at biotech startups, …

Continue ›››

Virtual Immunostaining for Digital Pathology

Owkin is a French-American startup, backed by Google Ventures among others, that deploys Artificial Intelligence (AI) and Federated Learning for medical research. The company was co-founded in 2016 by Thomas …

Continue ›››

[Interview] Advancing Off-the-shelf Cellular Medicines to Fight COVID-19

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected patients have been dosed with remestemcel-L, the company’s proprietary allogeneic …

Continue ›››

11 Inspiring Women Advancing Artificial Intelligence In Life Sciences

In this post, we decided to highlight eleven entrepreneurial women, leading the way in applying advanced computational technologies, such as machine learning (ML), deep learning (DL), and other artificial intelligence …

Continue ›››

[Interview] Hacking Metabolomics With AI To Improve Clinical Research

Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative modalities and therapies, laser-sharped for a specific group of patients, …

Continue ›››

[Interview] Building Canada’s Life Sciences Community and Thinking Global

Canada has a firm place in the global life sciences ecosystem, being the tenth largest market for pharmaceutical sales, and home to America’s second-largest life sciences corridor. The country has …

Continue ›››

[Interview] Shaping European Life Sciences with AI

There is a great deal of hype and a lot of misconceptions among life science experts as to how AI can or can’t be applied in pharmaceutical research and business. …

Continue ›››

[Interview] Using Generative AI to Rapidly Identify Novel Therapies for COVID-19

Generative models have become one of the hottest areas in de-novo molecular design over just several years, basically revolutionizing our perception of what can be done with artificial intelligence in …

Continue ›››

Reporting First Direct Sequence of SARS-CoV-2 RNA

The Lachlan Coin and Sebastian Duchene teams and collaborators in the Department of Microbiology and Immunology, University of Melbourne, Australia, provided the first direct RNA sequence of the SARS-CoV-2, detailed …

Continue ›››

Synonymous Mutations Can Affect Protein Folding And Impair Cellular Fitness

Synonymous codon substitutions affect the mRNA coding sequence, but the encoded amino acid sequence remains unchanged. Therefore, ostensibly these substitutions do not affect the phenotype and are often ignored in …

Continue ›››

COVID-19 Forcing You To Go Digital? You’re Missing A Trick

Moments of crisis always mean change. In these times, it’s tempting to reach for quotes from leaders who successfully navigated through turbulent times. "Never let a good crisis go to waste," is …

Continue ›››